E-LIB Suche - Ergebnisse für: David, Kevin

1

Impact of race and social determinants of health on outcome..:

Karmali, Reem ; Machhi, Rushad ; Epperla, Narendranath...
Blood Advances. 8 (2024) 10 - p. 2592-2599 , 2024

Link: https://doi.org/10.1182/..

2

Subsequent malignant neoplasms in patients previously treat..:

Melody, Megan ; Epperla, Narendranath ; Shouse, Geoffrey...
Blood Advances. 8 (2024) 10 - p. 2327-2331 , 2024

Link: https://doi.org/10.1182/..

3

Checkpoint Inhibitors Based Salvage Regimens Lead to Higher..:

Desai, Sanjal H ; Spinner, Michael A ; David, Kevin...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S32-S33 , 2023

Link: https://doi.org/10.1016/..

4

Impact of cumulative dose of brentuximab vedotin on outcome..:

Steiner, Raphael E. ; Hwang, Steven R. ; Khurana, Arushi...
Blood Advances. 7 (2023) 24 - p. 7485-7493 , 2023

Link: https://doi.org/10.1182/..

5

Outcomes of patients with secondary central nervous system ..:

Epperla, Narendranath ; Feng, Lei ; Shah, Nirav N....
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

6

Checkpoint inhibitor‐based salvage regimens prior to autolo..:

Desai, Sanjal H. ; Spinner, Michael A. ; David, Kevin...
American Journal of Hematology. 98 (2023) 3 - p. 464-471 , 2023

Link: https://doi.org/10.1002/..

7

Older patients with primary central nervous system lymphoma..:

David, Kevin A. ; Sundaram, Suchitra ; Kim, Seo‐Hyun...
American Journal of Hematology. 98 (2023) 6 - p. 900-912 , 2023

Link: https://doi.org/10.1002/..

8

Peri–CAR-T practice patterns and survival predictors for al..:

Zurko, Joanna ; Nizamuddin, Imran ; Epperla, Narendranath...
Blood Advances. 7 (2023) 12 - p. 2657-2669 , 2023

Link: https://doi.org/10.1182/..

9

Postibrutinib relapse outcomes for patients with marginal z..:

Epperla, Narendranath ; Zhao, Qiuhong ; Chowdhury, Sayan Mullick...
Blood Advances. 7 (2023) 1 - p. 88-91 , 2023

Link: https://doi.org/10.1182/..

10

Predictive factors and outcomes for ibrutinib in relapsed/r..:

Epperla, Narendranath ; Zhao, Qiuhong ; Chowdhury, Sayan Mullick...
Journal of Hematology & Oncology. 15 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

11

Open-label, phase 2 study of blinatumomab after frontline R..:

Katz, Deborah A. ; Morris, Joan D. ; Chu, Michael P....
Leukemia & Lymphoma. 63 (2022) 9 - p. 2063-2073 , 2022

Link: https://doi.org/10.1080/..

12

T100: Long term Follow-up of a Phase I Study Combinations o..:

Diefenbach, Catherine ; Jegede, Opeyemi ; Ambinder, Richard...
HemaSphere. 6 (2022) - p. 46-47 , 2022

Link: https://doi.org/10.1097/..

13

Dural Marginal Zone Lymphoma With Extensive Crystal Storing..:

Morgan, Katherine M ; Obiorah, Ifeyinwa ; Sun, Hai...
Journal of Neuropathology & Experimental Neurology. 81 (2022) 8 - p. 658-661 , 2022

Link: https://doi.org/10.1093/..

14

Autologous stem cell transplantation after anti-PD-1 therap..:

Merryman, Reid W. ; Redd, Robert A. ; Nishihori, Taiga...
Blood Advances. 5 (2021) 6 - p. 1648-1659 , 2021

Link: https://doi.org/10.1182/..

15

Impact of initial chemotherapy regimen on outcomes for pati..:

D'Angelo, Christopher R. ; Hanel, Walter ; Chen, Yi...
Hematological Oncology. 39 (2021) 4 - p. 473-482 , 2021

Link: https://doi.org/10.1002/..